Cannabinoids: From pot to lab

Esther Papaseit; Clara Pérez-Mañá; Ana Pilar Pérez-Acevedo; Olga Hladun; M. Carmen Torres-Moreno; Robert Muga; Marta Torrens; Magí Farré

doi:10.7150/ijms.27087

Cannabinoids: From pot to lab

Esther Papaseit, Clara Pérez-Mañá, Ana Pilar Pérez-Acevedo, Olga Hladun, M. Carmen Torres-Moreno, Robert Muga, Marta Torrens, Magí Farré

Research output: Contribution to journal › Review article › Research › peer-review

56 Citations (Scopus)

Abstract

© Ivyspring International Publisher. Cannabis is becoming increasingly present in our society. In recent years, the line between the natural (cannabis) and the synthetic (synthetic cannabinoids), the recreational (cannabis) and the medical (pharmaceutical cannabinoids and medical cannabis) has been crossed. In this paper we review some of the novel aspects of cannabis and cannabinoids in relation to their legal situation, changes in their composition and forms of cannabis use, the concept of medical cannabis, and synthetic cannabinoids as new psychoactive substances (NPS). We have also analyzed serious adverse reactions and intoxications associated with the use of synthetic cannabinoids, as well as the latest developments in the research of pharmaceutical cannabinoids.

Original language	English
Pages (from-to)	1286-1295
Journal	International Journal of Medical Sciences
Volume	15
Issue number	12
DOIs	https://doi.org/10.7150/ijms.27087
Publication status	Published - 6 Aug 2018

Keywords

Cannabidiol (CBD)
Cannabis
Delta-9-tetrahydrocannabinol (THC)
Medical cannabis
Synthetic cannabinoid

Access to Document

10.7150/ijms.27087

https://ddd.uab.cat/record/228032

Cite this

@article{0d6fa6566fbc413daf3de70369736a70,

title = "Cannabinoids: From pot to lab",

abstract = "{\textcopyright} Ivyspring International Publisher. Cannabis is becoming increasingly present in our society. In recent years, the line between the natural (cannabis) and the synthetic (synthetic cannabinoids), the recreational (cannabis) and the medical (pharmaceutical cannabinoids and medical cannabis) has been crossed. In this paper we review some of the novel aspects of cannabis and cannabinoids in relation to their legal situation, changes in their composition and forms of cannabis use, the concept of medical cannabis, and synthetic cannabinoids as new psychoactive substances (NPS). We have also analyzed serious adverse reactions and intoxications associated with the use of synthetic cannabinoids, as well as the latest developments in the research of pharmaceutical cannabinoids.",

keywords = "Cannabidiol (CBD), Cannabis, Delta-9-tetrahydrocannabinol (THC), Medical cannabis, Synthetic cannabinoid",

author = "Esther Papaseit and Clara P{\'e}rez-Ma{\~n}{\'a} and P{\'e}rez-Acevedo, {Ana Pilar} and Olga Hladun and Torres-Moreno, {M. Carmen} and Robert Muga and Marta Torrens and Mag{\'i} Farr{\'e}",

year = "2018",

month = aug,

day = "6",

doi = "10.7150/ijms.27087",

language = "English",

volume = "15",

pages = "1286--1295",

journal = "International Journal of Medical Sciences",

issn = "1449-1907",

publisher = "Ivyspring International Publisher",

number = "12",

}

TY - JOUR

T1 - Cannabinoids: From pot to lab

AU - Papaseit, Esther

AU - Pérez-Mañá, Clara

AU - Pérez-Acevedo, Ana Pilar

AU - Hladun, Olga

AU - Torres-Moreno, M. Carmen

AU - Muga, Robert

AU - Torrens, Marta

AU - Farré, Magí

PY - 2018/8/6

Y1 - 2018/8/6

N2 - © Ivyspring International Publisher. Cannabis is becoming increasingly present in our society. In recent years, the line between the natural (cannabis) and the synthetic (synthetic cannabinoids), the recreational (cannabis) and the medical (pharmaceutical cannabinoids and medical cannabis) has been crossed. In this paper we review some of the novel aspects of cannabis and cannabinoids in relation to their legal situation, changes in their composition and forms of cannabis use, the concept of medical cannabis, and synthetic cannabinoids as new psychoactive substances (NPS). We have also analyzed serious adverse reactions and intoxications associated with the use of synthetic cannabinoids, as well as the latest developments in the research of pharmaceutical cannabinoids.

AB - © Ivyspring International Publisher. Cannabis is becoming increasingly present in our society. In recent years, the line between the natural (cannabis) and the synthetic (synthetic cannabinoids), the recreational (cannabis) and the medical (pharmaceutical cannabinoids and medical cannabis) has been crossed. In this paper we review some of the novel aspects of cannabis and cannabinoids in relation to their legal situation, changes in their composition and forms of cannabis use, the concept of medical cannabis, and synthetic cannabinoids as new psychoactive substances (NPS). We have also analyzed serious adverse reactions and intoxications associated with the use of synthetic cannabinoids, as well as the latest developments in the research of pharmaceutical cannabinoids.

KW - Cannabidiol (CBD)

KW - Cannabis

KW - Delta-9-tetrahydrocannabinol (THC)

KW - Medical cannabis

KW - Synthetic cannabinoid

U2 - 10.7150/ijms.27087

DO - 10.7150/ijms.27087

M3 - Review article

C2 - 30275754

SN - 1449-1907

VL - 15

SP - 1286

EP - 1295

JO - International Journal of Medical Sciences

JF - International Journal of Medical Sciences

IS - 12

ER -

Cannabinoids: From pot to lab

Abstract

Keywords

Access to Document

Fingerprint

Cite this